This clinical study will consist of a post-market evaluation of the accuracy and user satisfaction of the System in a high volume single academic site. The study will compare overall anesthesia provider satisfaction with the System and the current approach for delivering and charting IV bolus medications. A small cohort of anesthesia providers (5 anesthesiologists and 5 CRNAs) will treat 250 patients undergoing anesthesia using the System. BD will provide all study equipment on loan under the research agreement, and equipment will be removed at the conclusion of the study. It is anticipated the study will have a duration of several months. For the purposes of this study, the System will not interface with Epic nor any other hospital information system at the University of Pennsylvania. Study investigators will continue to chart in Epic as they routinely do. Any interaction with the System will be in parallel with Epic. The System has been FDA cleared for use in the United States. Refer to Protocol Number BDMDS-INT001 for more information.

You may be eligible for this study if you meet the following criteria:

• Conditions: BD Intelliport Medication Management System
• Age: 99 years or below
• Gender: All